Dhampure Speciality Sugars Limited allotted 8,80,000 convertible equity share warrants on a preferential basis at its Board Meeting on 11th May, 2026. The warrants were issued at ₹106 each — including a premium of ₹96 — aggregating to ₹9,32,80,000, with INR 2,33,20,000 received upfront. The allotment was distributed equally among four promoter and promoter group members: Mr. Sorabh Gupta, Mrs. Reena Gupta, Mr. Shrey Gupta, and Ms. Ananya Gupta, each receiving 2,20,000 warrants. Each warrant is convertible into one equity share within 18 months from the date of allotment, subject to payment of the remaining 75% of the issue price.

Dhampure Speciality Sugars Allots 8,80,000 Convertible Share Warrants to Promoters on Preferential Basis

Dhampure Speciality Sugars Limited convened a Board Meeting on 11th May, 2026, at which the Board of Directors approved the allotment of 8,80,000 convertible equity share warrants on a preferential basis. The allotment follows a special resolution passed by the members of the Company at their Extra Ordinary General Meeting held on 18th March, 2026, and is in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018.

Warrant Allotment Details

The warrants were issued at a price of ₹106 per warrant, which includes a premium of ₹96 per warrant over the face value of ₹10 per equity share. The total issue aggregates to ₹9,32,80,000. Prior to allotment, an amount of INR 2,33,20,000 — representing more than 25% of the issue price per warrant — was received as an upfront payment from the allottees. The In-Principle Approval for the allotment was granted by BSE Limited vide Letter No. LOD/PREF/SS/FIP/141/2026-27 dated 27th April, 2026.

The following table summarises the allotment details across the four allottees:

Allottee: Category Warrants Allotted Mr. Sorabh Gupta Promoter 2,20,000 Mrs. Reena Gupta Promoter 2,20,000 Mr. Shrey Gupta Promoter Group 2,20,000 Ms. Ananya Gupta Promoter Group 2,20,000 Total 8,80,000

Key Terms of the Warrants

Each warrant allotted is convertible into or exchangeable for one fully paid-up equity share of face value ₹10 of the Company. The key terms governing the conversion are outlined below:

Conversion ratio: 1 warrant = 1 fully paid-up equity share

Balance consideration: 75% of the issue price per warrant, payable at the time of allotment of equity shares

Conversion window: Within 18 months from the date of allotment of share warrants

Regulatory framework: SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018

Regulatory Compliance

The allotment was disclosed to BSE Limited pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board Meeting commenced at 2:30 P.M. and concluded at 4:00 P.M. on 11th May, 2026. The disclosure was signed by Shyam Sharma, Company Secretary and Compliance Officer (Membership No.: A78521), on behalf of Dhampure Speciality Sugars Limited.

Dhampure Speciality Sugars Limited has notified the Bombay Stock Exchange of an upcoming board meeting, scheduled for Monday, May 11, 2026. The meeting will be held at the company's corporate office located at 24, School Lane, near World Trade Center, New Delhi-110001, commencing at 2:30 P.M. The intimation was filed on May 4, 2026, in compliance with Regulation 30 of the applicable listing regulations.

Board Meeting Agenda

The board meeting has been convened to deliberate on the following key matters, as outlined in the official intimation submitted to the exchange:

Allotment of warrants to the promoter and promoter group, pursuant to the in-principal approval already obtained from BSE

Any other business with the permission of the chair

Meeting Details at a Glance

The following table summarises the key details of the scheduled board meeting:

Parameter: Details Meeting Date: Monday, May 11, 2026 Meeting Time: 2:30 P.M. Venue: 24, School Lane, Near World Trade Center, New Delhi-110001 Primary Agenda: Allotment of warrants to promoter and promoter group Approval Basis: In-principal approval obtained from BSE Intimation Date: May 4, 2026

Regulatory Filing

The intimation was addressed to the Manager (Listing) at the Bombay Stock Exchange Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400001. The filing was signed by Shyam Sharma, Company Secretary and Compliance Officer (Membership No: A78521), on behalf of Dhampure Speciality Sugars Limited. The company has requested the exchange to take the information on record.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

Source: scanx.trade